Saturday,

February 15, 2020

6:30am-7:30am

Marriott Grand Ballroom 11-12

Marriott Marquis San Diego Marina San Diego, California

Download live activity resources and claim your CME credit.

 RESOURCES

Faculty

Stewart J. Tepper, MD

Professor of Neurology,

Geisel School of Medicine at Dartmouth

Director, Dartmouth Headache Center

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire

Wade M. Cooper, DO

Associate Professor of Neurology,

Michigan Medicine

Director,

Headache and Neuropathic Pain Program

University of Michigan

Ann Arbor, Michigan

Merle L. Diamond, MD

President and Managing Director,

Diamond Headache Clinic

Chicago, Illinois

AGENDA

6:30AM-7:30AM

Welcome and Session Overview

Breakfast Provided

 

Pathophysiology and Mechanism of Action Depicted in Mixed Reality

 

CASES IN EPISODIC MIGRAINE AND EPISODIC CLUSTER HEADACHE

 

Question and Answer Session

 

Adjournment

ACTIVITY INFORMATION

ACTIVITY DESCRIPTION

Delve deep into the scientific advances in migraine and episodic cluster headache (eCH) through a mixed reality experience as faculty demonstrate the intricacies of acute and preventive treatments with a HoloLens device. This CME presentation features a case series and faculty discussion to strengthen expertise in treating migraine and eCH to alleviate patient burden and improve their quality of life.

 

TARGET AUDIENCE

The target audiences are headache specialists and PCPs. Other healthcare professionals who treat patients with migraine, including general neurologists, physician assistants, nurse practitioners, nurses, and pharmacists, may benefit from participation.

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to

1. Apply

2. Develop

3. Effectively

4. Analyze

5. Discuss

Apply concepts in migraine pathophysiology and therapeutic mechanism of action (MOA) to treatment discussions

Develop treatment plans in line with current standards of practice and guidelines for the management of migraine and eCH

Effectively communicate with patients using shared decision making (SDM) to diagnose and treat headache disorders

Analyze safety and efficacy profiles for new and emerging therapies in acute and preventive treatment of migraine and eCH

Discuss burden of migraine and eCH and impact to quality of life (QoL)

CME INFORMATION

CREDIT DESIGNATION STATEMENT

ACCME: Forefront Collaborative designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

ABPN MOC: The American Board of Psychiatry and Neurology has reviewed Exploring Within: A Mixed Reality Look Into Migraine and Episodic Cluster and has approved this program as part of a comprehensive program, which is mandated by the ABMS as a necessary component of maintenance of certification.

 

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

ACCREDITATION STATEMENT

Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

DISCLOSURE STATEMENT

Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). The disclosures will be listed in the activity handout.

The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative or Lilly.

 

This continuing medical education activity will include reference(s) to unlabeled or unapproved uses of drugs or devices.

 

The following industry-supported symposium is held in conjunction with the Diamond Headache Clinic Research & Educational Foundation Meeting.

 

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

 

Forefront Collaborative complies with the Americans with Disabilities Act and will make every reasonable effort to accommodate your request. For special requests, please call Sydney Pate at 317.617.3897 prior to this activity.

630 W. Carmel Drive, Suite 260

Carmel, Indiana 46032

P 317.814.3126

Saturday,

February 15, 2020

6:30Am-7:30Am

Marriott Grand Ballroom 11-12

Marriott Marquis San Diego Marina San Diego, California